sapindoside b has been researched along with oleanolic acid in 6 studies
| Studies (sapindoside b) | Trials (sapindoside b) | Recent Studies (post-2010) (sapindoside b) | Studies (oleanolic acid) | Trials (oleanolic acid) | Recent Studies (post-2010) (oleanolic acid) |
|---|---|---|---|---|---|
| 6 | 0 | 4 | 4,169 | 31 | 2,404 |
| Protein | Taxonomy | sapindoside b (IC50) | oleanolic acid (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2.045 | |
| Phospholipase A2 | Homo sapiens (human) | 3 | |
| DNA polymerase beta | Homo sapiens (human) | 6.8667 | |
| DNA polymerase beta | Rattus norvegicus (Norway rat) | 5.6 | |
| Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) | 1 | |
| Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) | 3.065 | |
| Tissue factor | Homo sapiens (human) | 0.005 | |
| Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 4.38 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 2.8444 | |
| Liver carboxylesterase 1 | Homo sapiens (human) | 0.1 | |
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 3.065 | |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | 0.98 | |
| Dual specificity protein phosphatase 3 | Homo sapiens (human) | 5.4 | |
| Transcription factor p65 | Homo sapiens (human) | 2.4 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 3.065 | |
| Protease | Human immunodeficiency virus 1 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, XS; Mao, Q | 1 |
| Liu, GT; Shi, JZ | 1 |
| Chen, L; Chen, XZ; Da-Wa, ZM; Ding, LS; Fang, DM; Gu, YC; Guo, DL; Xia, B; Xu, HX; Zhao, M; Zhou, Y | 1 |
| Hu, X; Lin, M; Qiu, Y; Wu, G; Zhang, Q; Zheng, Y; Zhu, W | 1 |
| Cheng, YL; Guo, YH; Wei, MP; Xie, YF; Yao, WR; Yu, H | 2 |
6 other study(ies) available for sapindoside b and oleanolic acid
| Article | Year |
|---|---|
[Studies on the chemical constituents of Lonicera fulvotomentosa Hsu et S.C. Cheng].
Topics: Chemical Phenomena; Chemistry; Drugs, Chinese Herbal; Oleanolic Acid; Saponins | 1989 |
Effect of alpha-hederin and sapindoside B on hepatic microsomal cytochrome P-450 in mice.
Topics: Animals; Cytochrome P-450 Enzyme System; Drugs, Chinese Herbal; Male; Mice; Microsomes, Liver; Oleanolic Acid; Phenobarbital; Saponins | 1996 |
Cytotoxic triterpenoid saponins from Clematis tangutica.
Topics: Antineoplastic Agents, Phytogenic; Clematis; Drug Screening Assays, Antitumor; Hep G2 Cells; HL-60 Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Oleanolic Acid; Phytotherapy; Plant Roots; Saponins; Triterpenes | 2016 |
Potential Cytotoxicity, Pharmacokinetics, and Excretion Properties of Sapindoside B from the Seeds of Nigella sativa var. hispidula.
Topics: Animals; China; Chromatography, Liquid; Humans; Nigella sativa; Oleanolic Acid; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Saponins; Seeds; Tandem Mass Spectrometry | 2020 |
Potent in vitro synergistic antibacterial activity of natural amphiphilic Sapindoside A and B against Cutibacterium acnes with destructive effect on bacterial membrane.
Topics: Anti-Bacterial Agents; Cell Wall; Drug Synergism; In Vitro Techniques; Membrane Proteins; Microbial Sensitivity Tests; Oleanolic Acid; Propionibacteriaceae; Saponins; Spectrum Analysis, Raman | 2021 |
Synergistic combination of Sapindoside A and B: A novel antibiofilm agent against Cutibacterium acnes.
Topics: Anti-Bacterial Agents; Biofilms; Drug Synergism; Molecular Docking Simulation; Oleanolic Acid; Propionibacteriaceae; Saponins | 2022 |